Please enable JavaScript to continue using this application.

Compare $A vs $WST | Chartloom

Compare

$A vs $WST

Agilent Technologies Inc · West Pharmaceutical Services Inc

Agilent Technologies Inc

WST

West Pharmaceutical Services Inc

Compare $A vs $WST

Comparing Agilent Technologies Inc and West Pharmaceutical Services Inc

AAgilent Technologies Inc

WSTWest Pharmaceutical Services Inc

AAgilent Technologies Inc

Market cap

$48.17B

P/E (TTM)

33.52x

Forward P/E (NTM)

25.49x

Forward P/S (NTM)

6.01x

Rev growth (TTM)

8.6%

YTD performance

23.6%

52W performance

21.1%

FCF yield

2.6%

WSTWest Pharmaceutical Services Inc

Market cap

$25.76B

P/E (TTM)

46.20x

Forward P/E (NTM)

39.00x

Forward P/S (NTM)

7.45x

Rev growth (TTM)

12.4%

YTD performance

32.4%

52W performance

36.6%

FCF yield

1.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

WST

Detailed metrics comparison

Agilent Technologies Inc

WST

West Pharmaceutical Services Inc

Market Cap

A$48.17B

WST$25.76B

Enterprise Value

A$50.36B

WST$25.53B

Price

A$170.54

WST$366.00

P/E Ratio

A33.52x

WST46.20x

P/S Ratio

A6.53x

WST7.74x

EV/Sales

A6.83x

WST7.67x

EV/EBITDA

A25.81x

WST28.16x

P/B Ratio

A6.42x

WST8.84x

P/FCF Ratio

A38.02x

WST58.96x

EV/FCF

A39.74x

WST58.44x

PEG Ratio

A3.61x

WST3.05x

Forward P/E (NTM)

A25.49x

WST39.00x

Forward P/S (NTM)

A6.01x

WST7.45x

Revenue (TTM)

A$7.37B

WST$3.33B

Revenue Growth (YoY)

A8.6%

WST12.4%

Forward Rev Growth

A6.5%

WST6.2%

Gross Margin (TTM)

A53.9%

WST36.8%

Operating Margin (TTM)

A22.2%

WST20.4%

EBITDA Margin (TTM)

A26.4%

WST27.0%

Net Margin (TTM)

A19.5%

WST17.0%

FCF Margin (TTM)

A17.2%

WST13.1%

Net Income (TTM)

A$1.44B

WST$565M

FCF (TTM)

A$1.27B

WST$437M

EPS (TTM)

A$5.09

WST$7.92

ROE (TTM)

A20.5%

WST18.5%

ROA (TTM)

A11.0%

WST13.6%

ROIC (TTM)

A13.7%

WST17.3%

Cash

A$1.76B

WST$436M

Debt

A$3.95B

WST$207M

Net Cash/Debt

A$-2.19B

WST$229M

Current Ratio (TTM)

A2.05x

WST2.82x

Quick Ratio (TTM)

A1.56x

WST2.12x

Debt/Equity (TTM)

A0.54x

WST0.07x

Debt/Assets (TTM)

A0.0%

WST0.0%

Interest Coverage (TTM)

AN/A

WSTN/A

Net Debt/EBITDA (TTM)

A0.00x

WST0.00x

Beta

A1.25

WST1.15

52W Performance

A21.1%

WST36.6%

YTD Performance

A23.6%

WST32.4%

% from 52W High

A-3.7%

WST-5.2%

% from 52W Low

A57.4%

WST63.5%

Asset Turnover (TTM)

A0.56x

WST0.80x

FCF Yield (TTM)

A2.6%

WST1.7%

Earnings Yield (TTM)

A3.0%

WST2.2%

Dividend Yield (TTM)

A0.6%

WST0.2%

Rule of 40

A25.8

WST25.5

EV/GP/RG

A1.45

WST5.32

Ticker research

View A research View WST research

Metric	A Agilent Technologies Inc	WST West Pharmaceutical Services Inc
Market & Valuation
Market Cap	$48.17B	$25.76B
Enterprise Value	$50.36B	$25.53B
Price	$170.54	$366.00
P/E Ratio	33.52x	46.20x
P/S Ratio	6.53x	7.74x
EV/Sales	6.83x	7.67x
EV/EBITDA	25.81x	28.16x
P/B Ratio	6.42x	8.84x
P/FCF Ratio	38.02x	58.96x
EV/FCF	39.74x	58.44x
PEG Ratio	3.61x	3.05x
Forward P/E (NTM)	25.49x	39.00x
Forward P/S (NTM)	6.01x	7.45x
Revenue & Growth
Revenue (TTM)	$7.37B	$3.33B
Revenue Growth (YoY)	8.6%	12.4%
Forward Rev Growth	6.5%	6.2%
Profitability
Gross Margin (TTM)	53.9%	36.8%
Operating Margin (TTM)	22.2%	20.4%
EBITDA Margin (TTM)	26.4%	27.0%
Net Margin (TTM)	19.5%	17.0%
FCF Margin (TTM)	17.2%	13.1%
Net Income (TTM)	$1.44B	$565M
FCF (TTM)	$1.27B	$437M
EPS (TTM)	$5.09	$7.92
ROE (TTM)	20.5%	18.5%
ROA (TTM)	11.0%	13.6%
ROIC (TTM)	13.7%	17.3%
Financial Health
Cash	$1.76B	$436M
Debt	$3.95B	$207M
Net Cash/Debt	$-2.19B	$229M
Current Ratio (TTM)	2.05x	2.82x
Quick Ratio (TTM)	1.56x	2.12x
Debt/Equity (TTM)	0.54x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.25	1.15
52W Performance	21.1%	36.6%
YTD Performance	23.6%	32.4%
% from 52W High	-3.7%	-5.2%
% from 52W Low	57.4%	63.5%
Efficiency & Yields
Asset Turnover (TTM)	0.56x	0.80x
FCF Yield (TTM)	2.6%	1.7%
Earnings Yield (TTM)	3.0%	2.2%
Dividend Yield (TTM)	0.6%	0.2%
Other
Rule of 40	25.8	25.5
EV/GP/RG	1.45	5.32
Ticker research	View A research	View WST research

Valuation

P/E Ratio

33.52x

WST

46.20x

P/S Ratio

6.53x

WST

7.74x

EV/FCF

39.74x

WST

58.44x

Growth & revenue

Revenue Growth TTM

WST

12.4%

8.6%

Forward Revenue Growth

6.5%

WST

6.2%

Profitability & performance

Gross Margin

53.9%

WST

36.8%

ROE

20.5%

WST

18.5%

FCF Yield %

2.6%

WST

1.7%

52-Week Performance

WST

36.6%

21.1%

Detailed metrics comparison

Agilent Technologies Inc

WST

West Pharmaceutical Services Inc

Market Cap

A$48.17B

WST$25.76B

Enterprise Value

A$50.36B

WST$25.53B

Price

A$170.54

WST$366.00

P/E Ratio

A33.52x

WST46.20x

P/S Ratio

A6.53x

WST7.74x

EV/Sales

A6.83x

WST7.67x

EV/EBITDA

A25.81x

WST28.16x

P/B Ratio

A6.42x

WST8.84x

P/FCF Ratio

A38.02x

WST58.96x

EV/FCF

A39.74x

WST58.44x

PEG Ratio

A3.61x

WST3.05x

Forward P/E (NTM)

A25.49x

WST39.00x

Forward P/S (NTM)

A6.01x

WST7.45x

Revenue (TTM)

A$7.37B

WST$3.33B

Revenue Growth (YoY)

A8.6%

WST12.4%

Forward Rev Growth

A6.5%

WST6.2%

Gross Margin (TTM)

A53.9%

WST36.8%

Operating Margin (TTM)

A22.2%

WST20.4%

EBITDA Margin (TTM)

A26.4%

WST27.0%

Net Margin (TTM)

A19.5%

WST17.0%

FCF Margin (TTM)

A17.2%

WST13.1%

Net Income (TTM)

A$1.44B

WST$565M

FCF (TTM)

A$1.27B

WST$437M

EPS (TTM)

A$5.09

WST$7.92

ROE (TTM)

A20.5%

WST18.5%

ROA (TTM)

A11.0%

WST13.6%

ROIC (TTM)

A13.7%

WST17.3%

Cash

A$1.76B

WST$436M

Debt

A$3.95B

WST$207M

Net Cash/Debt

A$-2.19B

WST$229M

Current Ratio (TTM)

A2.05x

WST2.82x

Quick Ratio (TTM)

A1.56x

WST2.12x

Debt/Equity (TTM)

A0.54x

WST0.07x

Debt/Assets (TTM)

A0.0%

WST0.0%

Interest Coverage (TTM)

AN/A

WSTN/A

Net Debt/EBITDA (TTM)

A0.00x

WST0.00x

Beta

A1.25

WST1.15

52W Performance

A21.1%

WST36.6%

YTD Performance

A23.6%

WST32.4%

% from 52W High

A-3.7%

WST-5.2%

% from 52W Low

A57.4%

WST63.5%

Asset Turnover (TTM)

A0.56x

WST0.80x

FCF Yield (TTM)

A2.6%

WST1.7%

Earnings Yield (TTM)

A3.0%

WST2.2%

Dividend Yield (TTM)

A0.6%

WST0.2%

Rule of 40

A25.8

WST25.5

EV/GP/RG

A1.45

WST5.32

Ticker research

View A research View WST research

Metric	A Agilent Technologies Inc	WST West Pharmaceutical Services Inc
Market & Valuation
Market Cap	$48.17B	$25.76B
Enterprise Value	$50.36B	$25.53B
Price	$170.54	$366.00
P/E Ratio	33.52x	46.20x
P/S Ratio	6.53x	7.74x
EV/Sales	6.83x	7.67x
EV/EBITDA	25.81x	28.16x
P/B Ratio	6.42x	8.84x
P/FCF Ratio	38.02x	58.96x
EV/FCF	39.74x	58.44x
PEG Ratio	3.61x	3.05x
Forward P/E (NTM)	25.49x	39.00x
Forward P/S (NTM)	6.01x	7.45x
Revenue & Growth
Revenue (TTM)	$7.37B	$3.33B
Revenue Growth (YoY)	8.6%	12.4%
Forward Rev Growth	6.5%	6.2%
Profitability
Gross Margin (TTM)	53.9%	36.8%
Operating Margin (TTM)	22.2%	20.4%
EBITDA Margin (TTM)	26.4%	27.0%
Net Margin (TTM)	19.5%	17.0%
FCF Margin (TTM)	17.2%	13.1%
Net Income (TTM)	$1.44B	$565M
FCF (TTM)	$1.27B	$437M
EPS (TTM)	$5.09	$7.92
ROE (TTM)	20.5%	18.5%
ROA (TTM)	11.0%	13.6%
ROIC (TTM)	13.7%	17.3%
Financial Health
Cash	$1.76B	$436M
Debt	$3.95B	$207M
Net Cash/Debt	$-2.19B	$229M
Current Ratio (TTM)	2.05x	2.82x
Quick Ratio (TTM)	1.56x	2.12x
Debt/Equity (TTM)	0.54x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.25	1.15
52W Performance	21.1%	36.6%
YTD Performance	23.6%	32.4%
% from 52W High	-3.7%	-5.2%
% from 52W Low	57.4%	63.5%
Efficiency & Yields
Asset Turnover (TTM)	0.56x	0.80x
FCF Yield (TTM)	2.6%	1.7%
Earnings Yield (TTM)	3.0%	2.2%
Dividend Yield (TTM)	0.6%	0.2%
Other
Rule of 40	25.8	25.5
EV/GP/RG	1.45	5.32
Ticker research	View A research	View WST research